| Teva Pharmaceutical Industries Ltd ADR (TEVA) | |||
|---|---|---|---|
| 10.13 -0.01 (-0.1%) | 10-22 16:00 | ||
| Open: | 10.12 | Pre. Close: | 10.14 |
| High: | 10.18 | Low: | 9.92 |
| Volume: | 5,867,229 | Market Cap: | 11,225M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 10.148 - 10.199 | 10.199 - 10.232 |
| Low: | 9.797 - 9.865 | 9.865 - 9.909 |
| Close: | 10.031 - 10.135 | 10.135 - 10.202 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 12.01 One year: 14.02 |
| Support: | Support1: 9.24 Support2: 8.59 |
| Resistance: | Resistance1: 10.28 Resistance2: 12.01 |
| Pivot: | 9.93  |
| Moving Averages: | MA(5): 10.05 MA(20): 9.86 MA(100): 9.68  MA(250): 10.28 |
| MACD: | MACD(12,26): 0.18 Signal(12,26,9): 0.16 |
| %K %D: | %K(14,3): 81.89 %D(3): 77.22 |
| RSI: | RSI(14): 62.22 |
| 52-Week: | High: 13.3 Low: 8.24 Change(%): 11.1 |
| Average Vol(K): | 3-Month: 698919 10-Days: 596852 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.TEVA has closed below upper band by 25.1%. Bollinger Bands are 38.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency |  |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers—Specialty & Generic | |
| Shares Out. (M) | 1100.00 |
| Shares Float (M) | 1100.00 |
| % Held by Insiders | 1.05 |
| % Held by Institutions | 51.07 |
| Shares Short (K) | 22230 |
| Shares Short Prior Month (K) | 28530 |
| Stock Financials | |
|---|---|
| EPS | -3.630 |
| Book Value (p.s.) | 9.070 |
| Profit Margin | -23.98 |
| Operating Margin | 18.13 |
| Return on Assets (ttm) | 3.5 |
| Return on Equity (ttm) | -29.6 |
| Qtrly Rev. Growth | |
| Gross Profit (p.s.) | 7.027 |
| Sales Per Share | 14.836 |
| EBITDA (p.s.) | 4.018 |
| Qtrly Earnings Growth | 47.90 |
| Operating Cash Flow (M) | 451.00 |
| Levered Free Cash Flow (M) | 1300.00 |
| Stock Valuation | |
|---|---|
| PE Ratio | -2.79 |
| PEG Ratio | |
| Price to Book value | 1.12 |
| Price to Sales | 0.68 |
| Price to Cash Flow | 24.71 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
